Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03731481 · ClinicalTrials.gov registry record · NA

Virtual Lifestyle Medicine Comparative Effectiveness Research

A NA study of Obesity and Depression, sponsored by Ohio University.

Completed
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT03731481: Completed NA study of Obesity and Depression, sponsored by Ohio University.

NCT03731481 is a NA study of Obesity and Depression that has completed, run by Ohio University. The registered enrollment target is 46 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03731481, a NA study of Obesity and Depression, has completed, sponsored by Ohio University.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the effectiveness of two online Lifestyle Medicine programs. Participants will be randomized by residence, urban vs. rural, into one of two Lifestyle Medicine programs.

Primary Outcome

Measure of number of sign-ins and class attendance

Interventions

  • BEHAVIORAL Lifestyle Medicine

Study Locations (1)

Ohio

  • Ohio University - Athens

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2017-05-31
Est. Completion 2018-07-01
Phase NA
Ohio University

51 total trials

What the finished NCT03731481 record still lists

NCT03731481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Lifestyle Medicine is the first listed.

NCT03731481 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT03731481 about?

NCT03731481 is a clinical study titled "Virtual Lifestyle Medicine Comparative Effectiveness Research". This study evaluates the effectiveness of two online Lifestyle Medicine programs. Participants will be randomized by residence, urban vs. rural, into one of two Lifestyle Medicine programs.

What is the current status of trial NCT03731481?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2017-05-31. Estimated completion is 2018-07-01.

What conditions does trial NCT03731481 study?

This clinical trial studies the following conditions: Obesity, Depression, Chronic Disease, Sleep Disorder.

What interventions are being tested in trial NCT03731481?

The interventions under investigation include: Lifestyle Medicine (BEHAVIORAL).

Who is sponsoring clinical trial NCT03731481?

This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03731481 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03731481's enrollment target sits among peer trials

46 743rd of 1053 higher than 303 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03731481, the US trial registry maintained by the National Library of Medicine. NCT03731481 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.